Literature DB >> 14629467

Factor XI apple domains and protein dimerization.

Q Cheng1, M-F Sun, D V Kravtsov, A Aktimur, D Gailani.   

Abstract

The coagulation protease zymogen factor (F)XI is a disulfide bond-linked homodimer, a configuration that is necessary for protein secretion and function. The non-catalytic portion of the FXI polypeptide contains four repeats called apple domains (A1-A4). It is clear that FXI A4 plays a key role in dimer formation, however, the importance of other apple domains to this process has not been examined. We prepared recombinant FXI molecules in which apple domains were exchanged with those of the structurally homologous monomeric protein prekallikrein (PK). As expected, FXI/PK chimeras containing FXI A4 are dimers, while those with PK A4 are monomers. FXI A4 contains cysteine at position 321 that forms the interchain disulfide bond, while Cys321 in PK is unavailable for interchain bond formation because it is paired with Cys326. FXI/PK chimeras containing PK A4 were modified by changing Cys326 to glycine, leaving Cys321 unpaired (PKA4-Gly326). FXI with a PK A4 domain is a monomer, however, introducing PKA4-Gly326 results in a disulfide bond-linked dimer. This indicates that dimer formation can occur in the absence of FXI A4. In proteins containing PKA4-Gly326, replacing FXI A3 with PK A3 partially interferes with dimer formation, while substitution of A2, or A2 and A3 prevents dimer formation. PKA4-Gly326 cannot induce the native PK molecule to dimerize. The data indicate that FXI A2 and A3 make contributions to dimer formation. As these domains are involved in activities that require dimeric protein, it seems reasonable that they stabilize this conformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629467     DOI: 10.1046/j.1538-7836.2003.00418.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  11 in total

1.  Structural modules for receptor dimerization in the S-locus receptor kinase extracellular domain.

Authors:  Sushma Naithani; Thanat Chookajorn; Daniel R Ripoll; June B Nasrallah
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

2.  A sequential mechanism for exosite-mediated factor IX activation by factor XIa.

Authors:  Yipeng Geng; Ingrid M Verhamme; Amanda Messer; Mao-fu Sun; Stephen B Smith; S Paul Bajaj; David Gailani
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

3.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

Review 4.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

5.  Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).

Authors:  Tara C White-Adams; Michelle A Berny; Erik I Tucker; Jacqueline M Gertz; David Gailani; Rolf T Urbanus; Philip G de Groot; András Gruber; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

6.  An insertion mutation of the bovine Fii gene is responsible for factor XI deficiency in Japanese black cattle.

Authors:  Masaki Kunieda; Takehito Tsuji; Abdol Rahim Abbasi; Maryam Khalaj; Miho Ikeda; Keiko Miyadera; Hiroyuki Ogawa; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

Review 7.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

8.  Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.

Authors:  Stephen B Smith; Ingrid M Verhamme; Mao-fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

9.  The dimeric structure of factor XI and zymogen activation.

Authors:  Yipeng Geng; Ingrid M Verhamme; Stephen B Smith; Mao-Fu Sun; Anton Matafonov; Qiufang Cheng; Stephanie A Smith; James H Morrissey; David Gailani
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

Review 10.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.